Press release
Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer (ALK-NSCLC) Market Anticipating Remarkable Growth by 2032, Insights by DelveInsight | GlaxoSmithKline, Novartis, AstraZeneca, Pfizer, Roche, Merck, Ariad Pharmaceutica, Takeda, Akeso
DelveInsight's "Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the ALK-NSCLC Market Size and Share in the seven major markets (7MM) (i.e., the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom and Japan).
The market report covers emerging drugs, treatment practices, market share of individual ALK-NSCLC therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of opportunities and assess the underlying potential of the market.
Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer: An Overview
Lung cancer mainly begins in the lungs, and it may spread to lymph nodes or other organs in the body, such as the brain. However, cancer from other organs may also spread to the lungs. When cancer cells spread from one organ to another, they are called metastases.
There are mainly two types of lung cancer small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). NSCLC can be defined as any type of epithelial lung cancer other than SCLC. It is mainly subcategorized into adenocarcinomas, squamous cell carcinomas, large cell carcinomas and several other types that occur less frequently include adenosquamous carcinomas, and sarcomatoid
carcinomas.
There are several genetic mutations identified to play a major role in the progression of this indication. Mutations in EGFR, KRAS, and ALK are mutually exclusive in patients with NSCLC, and the presence of one mutation instead of another can influence response to targeted therapy.
Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer Market Key Facts
• The total incident population of NSCLC in the 7MM was assessed to be approximately 500,000 in 2022 and is expected to increase during the study period.
• Among the European countries, Germany had the highest incident population of NSCLC. Furthermore, Japan accounts for about 100,000 cases of the total 7MM incident population of NSCLC (in 2022).
• The highest number of NSCLCs were estimated in the United States.
• In histology-specific cases, Adenocarcinoma accounts for the highest number of cases, i.e., approximately 47% followed by Squamous Cell Carcinoma.
DelveInsight's analysts have estimated that in 2022, in the United States, there were around 9,000 incident cases of ALK-positive mutation.
Get a Detailed Overview of the Evolving Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer Market Trends @
https://www.delveinsight.com/report-store/anaplastic-lymphoma-kinase-non-small-cell-lung-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer Market
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted market size by analyzing the impact of current and emerging ALK-NSCLC therapies in the market. It also provides a detailed assessment of the ALK-NSCLC market drivers & barriers, unmet needs, and emerging technologies.
The report gives complete details of the market trend for each marketed ALK-NSCLC drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MOA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.
Discover How Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer Market Will Grow by 2032 @
https://www.delveinsight.com/report-store/anaplastic-lymphoma-kinase-non-small-cell-lung-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer Epidemiology
The epidemiology section covers detailed insights into the historical, and current Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer patient pool and forecasted epidemiology trends for every seven major countries (7MM) from 2019 to 2032.
The Report Covers the Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer Epidemiology Segmented as -
• Total Incidence of NSCLC in the 7MM [2019-2032]
• Total Diagnosed cases of NSCLC patients by Stages in the 7MM [2019-2032]
• Total Incident cases of NSCLC patients by Histology in the 7MM [2019-2032]
• Total ALK-NSCLC cases in the 7MM [2019-2032]
• ALK-NSCLC Treated Patient Pool in the 7MM [2019-2032]
Get Key Insights Into the Evolving Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer Epidemiology Trends @
https://www.delveinsight.com/sample-request/anaplastic-lymphoma-kinase-non-small-cell-lung-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer Drugs Uptake and Pipeline Development Activities
The drugs' uptake section focuses on the rate of uptake of the potential drugs recently launched in the ALK-NSCLC market or expected to be launched during the study period. The analysis covers the market share by ALK-NSCLC drugs, patient uptake by therapies, and sales of each drug.
The report's drugs uptake section helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs. It allows the comparison of the drugs based on market share and size, which again will be helpful in investigating factors important in understanding the market dynamics and in making financial and regulatory decisions.
The report also covers the ALK-NSCLC Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Explore More About Ongoing Pipeline Development Activities in the Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer Market @
https://www.delveinsight.com/sample-request/anaplastic-lymphoma-kinase-non-small-cell-lung-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer Therapeutics Assessment
Anaplastic Lymphoma Kinase (ALK), is a CD receptor (CD246) that plays a significant role in the development of neurons. The ALK gene products are known to promote cell growth/proliferation and inhibit apoptosis at baseline. There are several therapies approved under this category, such as ALUNBRIG (brigatinib), ZYKADIA (ceritinib), XALKORI (crizotinib), and ALECTINIB. Apart from this, LORBRENA (lorlatinib) is another therapy available for the ALK-positive NSCLC patient pool.
Several major pharma and biotech companies are developing therapies for Anaplastic Lymphoma Kinase (ALK) Positive, Advanced Non-Small Cell Lung Cancer. Currently, Xuanzhu Biopharmaceutical is leading the therapeutics market with its ALK-NSCLC drug candidates in the most advanced stage of clinical development.
Leading Companies in the Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer Therapeutics Market Include
GlaxoSmithKline, Novartis, AstraZeneca, Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck, Suzhou Zelgen Biopharmaceuticals Co.,Ltd, Ariad Pharmaceutica, Takeda, Chia Tai Tianqing Pharmaceutical Group, Akeso, and others.
Emerging and Marketed Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer Therapies Covered in the Report Include:
• XZP-3621: Xuanzhu Biopharmaceutical
• SAF-189: Reata Pharmaceuticals
And Many Others
Learn More About the Emerging Therapies and key Companies in the Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer Therapeutics Market @
https://www.delveinsight.com/sample-request/anaplastic-lymphoma-kinase-non-small-cell-lung-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer Competitive Intelligence Analysis
4. Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer Market Overview at a Glance
5. Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer Background and Overview
6. Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer Patient Journey
7. Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer Epidemiology and Patient Population
8. Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer Treatment Algorithm, Current Treatment, and Medical Practices
9. Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer Unmet Needs
10. Key Endpoints of Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer Treatment
11. Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer Marketed Products
12. Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer Emerging Therapies
13. Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer Seven Major Market Analysis
14. Attribute Analysis
15. Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer Market Outlook (7 major markets)
16. Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer Access and Reimbursement Overview
17. KOL Views on the Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer Market.
18. Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer Market Drivers
19. Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.
Download the Sample PDF to Get Detailed Insights About the Report's Offerings @
https://www.delveinsight.com/sample-request/anaplastic-lymphoma-kinase-non-small-cell-lung-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
------------------------------------------------------------------------------------------------------------------------------
Discover DelveInsight's Comprehensive Market Research and Consulting Services:
https://www.delveinsight.com/market-research
Elevate your industry insights with our comprehensive medical devices market assessment reports. Visit to gain a strategic edge through expert analysis and in-depth coverage of the latest trends, innovations, and market dynamics, at:
https://www.delveinsight.com/medical-devices
Empowering Cancer Care: DelveInsight's oncology consulting services offer personalized guidance and cutting-edge expertise to navigate the ongoing clinical, commercial, and regulatory developments, visit for more details:
https://www.delveinsight.com/oncology
Other Trending Healthcare Reports by DelveInsight
Pulmonology Devices Market
https://www.delveinsight.com/report-store/pulmonology-devices-market
Small Cell Lung Cancer Market
https://www.delveinsight.com/report-store/small-cell-lung-cancer-market
Bronchiectasis Market
https://www.delveinsight.com/report-store/bronchiectasis-market
Lennox Gastaut Syndrome Market
https://www.delveinsight.com/report-store/lennox-gastaut-syndrome-market
Holter Monitor Market
https://www.delveinsight.com/report-store/holter-monitor-market
Muscle Invasive Bladder cancer Market
https://www.delveinsight.com/report-store/muscle-invasive-bladder-cancer-market
Osteochondrodysplasia Market
https://www.delveinsight.com/report-store/osteochondrodysplasia-market
Anesthesia Machines Market
https://www.delveinsight.com/report-store/anesthesia-workstation-machines-market
Secondary Myelofibrosis Market
https://www.delveinsight.com/report-store/secondary-myelofibrosis-market
Guillain-Barre Syndrome (GBS) Market
https://www.delveinsight.com/report-store/guillain-barre-syndrome-gbs-market
Hepatitis A Market
https://www.delveinsight.com/report-store/hepatitis-a-market
Sickle Cell Disease Market
https://www.delveinsight.com/report-store/sickle-cell-disease-market
Mucinous Cystic Neoplasms (MCNs) Market
https://www.delveinsight.com/report-store/mucinous-cystic-neoplasms-mcns-market
Overt Hepatic Encephalopathy Market
https://www.delveinsight.com/report-store/overt-hepatic-encephalopathy-market
Familial Hypercholesterolemia Market
https://www.delveinsight.com/report-store/familial-hypercholesterolemia-market-report
Lateral Epicondylitis (Tennis Elbow) Disease Market
https://www.delveinsight.com/report-store/lateral-epicondylitis-tennis-elbow-disease-market
Diverticulitis Market
https://www.delveinsight.com/report-store/diverticulitis-market
Crows Feet Market
https://www.delveinsight.com/report-store/crows-feet-market
Helicobacter Pylori Infections Market
https://www.delveinsight.com/report-store/helicobacter-pylori-infections-market
Charcot-Marie-Tooth Disease Market
https://www.delveinsight.com/report-store/charcot-marie-tooth-disease-market
Neurovascular Thrombectomy Devices Market
https://www.delveinsight.com/report-store/neurovascular-thrombectomy-devices-market
Neurothrombectomy Devices Market
https://www.delveinsight.com/report-store/neurovascular-thrombectomy-devices-market
Stargardt Disease (STGD) Market
https://www.delveinsight.com/report-store/stargardt-disease-stgd-market
Venous Leg Ulcer Market
https://www.delveinsight.com/report-store/venous-leg-ulcer-market
Genital Herpes Market
https://www.delveinsight.com/report-store/genital-herpes-market-forecast
Idiopathic Thrombocytopenic Purpura Market
https://www.delveinsight.com/report-store/idiopathic-thrombocytopenic-purpura-market
Morquio Syndrome Market
https://www.delveinsight.com/report-store/morquio-syndrome-market
Lymphoedema Market
https://www.delveinsight.com/report-store/lymphoedema-market
Neurotrophic Keratopathy Market
https://www.delveinsight.com/report-store/neurotrophic-keratopathy-market
Oncolytic Virus Cancer Therapy Market
https://www.delveinsight.com/report-store/oncolytic-virus-cancer-therapy-market
Orthostatic Hypotension Market
https://www.delveinsight.com/report-store/orthostatic-hypotension-market
Advanced Wound Care (AWC) Market
https://www.delveinsight.com/report-store/advanced-wound-care-market
Opioid-related Disorders Market
https://www.delveinsight.com/report-store/opioid-related-disorders-market
Ankylosing Spondylitis (AS) Market
https://www.delveinsight.com/report-store/ankylosing-spondylitis-as-market
Chronic Insomnia Market
https://www.delveinsight.com/report-store/chronic-insomnia-market
Microscopic Polyangiitis (MPA) Market
https://www.delveinsight.com/report-store/microscopic-polyangiitis-mpa-market
Esophageal Squamous Carcinoma Market
https://www.delveinsight.com/report-store/esophageal-squamous-carcinoma-market
Hypertrophic Scar Market
https://www.delveinsight.com/report-store/hypertrophic-scar-market
Chemotherapy Induced Neutropenia (CIN) Market
https://www.delveinsight.com/report-store/chemotherapy-induced-neutropenia-cin-market
Idiopathic Interstitial Pneumonia Market
https://www.delveinsight.com/report-store/idiopathic-interstitial-pneumonia-market
Diphtheria Market
https://www.delveinsight.com/report-store/diphtheria-market
Dyslipidemia Market
https://www.delveinsight.com/report-store/dyslipidemia-market
Thymus Cancer Market
https://www.delveinsight.com/report-store/thymus-cancer-market
Tendonitis Market
https://www.delveinsight.com/report-store/tendonitis-market
Alpha-Antitrypsin Deficiency Market
https://www.delveinsight.com/report-store/alpha-antitrypsin-deficiency-market
Factor XA Inhibitor Market
https://www.delveinsight.com/report-store/factor-xa-inhibitor-market
Undifferentiated Pleomorphic Sarcoma Market
https://www.delveinsight.com/report-store/undifferentiated-pleomorphic-sarcoma-market
Carcinoid Tumor Syndrome Market
https://www.delveinsight.com/report-store/carcinoid-tumor-syndrome-market
Primary Progressive Multiple Sclerosis (PPMS) Market
https://www.delveinsight.com/report-store/primary-progressive-multiple-sclerosis-ppms-market
Thalassemia Market
https://www.delveinsight.com/report-store/thalassemia-market
Contact Info:
Shruti Thakur
Manager (Marketing & Branding)
Email: info@delveinsight.com
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer (ALK-NSCLC) Market Anticipating Remarkable Growth by 2032, Insights by DelveInsight | GlaxoSmithKline, Novartis, AstraZeneca, Pfizer, Roche, Merck, Ariad Pharmaceutica, Takeda, Akeso here
News-ID: 3249498 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
